Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market
Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform.
Tuesday, August 16, 2022 at 1:31 pm